IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

Abroad (travel likely)RecruitingPHASE3

Conditions

Nasopharyngeal Carcinoma · Immune Checkpoint Inhibitor · Radiotherapy · Chemotherapy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Cancer Center, Sun Yat-sen University, Guangzhou, Guangdong, China
Contact: Study coordinator (Chong Zhao, M.D) · zhaochong@sysucc.org.cn · 02087342638
The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China
Contact: Study coordinator (Min Kang, MD)
Jiangxi Cancer Hospital, Nanchang, Jiangxi, China
Contact: Study coordinator (Jingao Li)

Study leads

Chong Zhao, MD, PhD
Principal Investigator
Sun Yat-Sen University Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Reducing High Risk Primary Tumor Clinical Target Volumes (CTVp1) in Non-metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma · Intensity-Modulated Radiotherapy

Abroad (travel likely)Recruiting

Zhongshan, China

Under Whole-course of Immunotherapy, Gradient Fractionated RT with CCT Versus CFRT with CCT for LANPC Who Achieved PR Post Induction Chemotherapy.

Nasopharyngeal Carcinoma · De-escalation Therapy

Abroad (travel likely)RecruitingPHASE3

Zhuhai, China

ICCRT vs. CRT for Locally Advanced Nasopharyngeal Carcinoma

Locally Advanced Nasopharyngeal Carcinoma

Abroad (travel likely)RecruitingPHASE3

Guangzhou, China

Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma · High-Risk Cancer · Maintenance Therapy

Abroad (travel likely)RecruitingPHASE3

Ganzhou, China · Guangzhou, China